Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Ingham · SciRah

Researcher profile · Semantic Scholar

M. Ingham

Share profile

M. Ingham — researcher profile on SciRah

h-index: 12
Works: 75
Citations: 562

Most-cited papers

Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study.
N. Keks, M. Ingham, Akbar Khan, K. Karcher
2007The British journal of psychiatry : the journal of mental science90 citations Open access
Semantic Scholar
Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs
J. Lofland, Phaedra T. Johnson, M. Ingham, S. Rosemas +2 more
2017Patient Preference and Adherence79 citations Open access
Semantic Scholar
Reduction of Healthcare Resource Utilisation and Costs Following the Use of Risperidone for Patients with Schizophrenia Previously Treated with Standard Antipsychotic Therapy
P. Albright, S. Livingstone, D. Keegan, M. Ingham +2 more
199672 citations
Semantic Scholar
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
S. Merchant, C. Gast, D. Nathwani, Michael Lee +4 more
2008Clinical Therapeutics48 citations
Semantic Scholar
Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development
T. van Mierlo, Rachel Fournier, M. Ingham
2015PLoS ONE43 citations Open access
Semantic Scholar
Patient experience with intravenous biologic therapies for ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, psoriasis, rheumatoid arthritis, and ulcerative colitis
S. Bolge, H. Eldridge, J. Lofland, C. Ravin +2 more
2017Patient Preference and Adherence35 citations Open access
Semantic Scholar
The cost-effectiveness of atypicals in the UK.
B. Heeg, E. Buskens, M. Botteman, S. Caleo +4 more
2008Value in Health25 citations Open access
Semantic Scholar
The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis
C. Cameron, E. Ewara, F. Wilson, A. Varu +3 more
2017Medical decision making18 citations Open access
Semantic Scholar
Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin
E. Buysman, A. Anderson, Shaffeeulah Bacchus, M. Ingham
2017Advances in Therapy16 citations
Semantic Scholar
The impact of non-medical switching among ambulatory patients: an updated systematic literature review
E. Weeda, E. Nguyen, S. Martin, M. Ingham +3 more
2019Journal of Market Access & Health Policy14 citations Open access
Semantic Scholar
HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
C. Wysham, D. Pilon, M. Ingham, M. Lafeuille +4 more
2018Endocrine Practice13 citations
Semantic Scholar
Predicting Pre-emptive Discussions of Biologic Treatment: Results from an Openness and Preference Survey of Inflammatory Bowel Disease Patients and Their Prescribers
M. Kariburyo, Lin Xie, A. Teeple, H. Tan +1 more
2017Advances in Therapy13 citations Open access
Semantic Scholar
Treatment patterns, glycemic control & bodyweight with canagliflozin 300 mg versus GLP1RAs in Type II diabetes patients.
C. Coleman, S. Pandya, Li Wang, O. Baser +3 more
2019Journal of Comparative Effectiveness Research10 citations Open access
Semantic Scholar
Economic assessment of doripenem versus imipenem in the treatment of ventilator-associated pneumonia
L. Mcgarry, S. Merchant, D. Nathwani, V. Pawar +5 more
2010Journal of Medical Economics10 citations Open access
Semantic Scholar
Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting
C. Wysham, D. Pilon, M. Ingham, M. Lafeuille +4 more
2018Current Medical Research and Opinion9 citations
Semantic Scholar
Treatment patterns, economic burden, and overall survival in US Medicare Advantage beneficiaries newly diagnosed with acute myeloid leukemia (AML) in 2015–2020
S. Huntington, M. Ingham, Linda Okonkwo, Ajay Singh +2 more
2021Leukemia and Lymphoma8 citations
Semantic Scholar
Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA
M. Singhal, Hiangkiat Tan, C. Coleman, Michelle Han +2 more
2019BMJ Open Diabetes Research & Care8 citations Open access
Semantic Scholar
Comparative multidatabase analysis of dosing patterns and infusion intervals for the first 12 infliximab infusions in patients with rheumatoid arthritis.
S. Bolge, C. Carter, C. Mueller, R. Bailey +1 more
2012Clinical Therapeutics7 citations Open access
Semantic Scholar
An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.
C. Wysham, P. Lefebvre, D. Pilon, M. Lafeuille +5 more
2019Journal of diabetes and its complications6 citations Open access
Semantic Scholar
The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage
A. Panzer, M. Ingham, S. Martin, J. Chambers
2023Journal of Managed Care & Specialty Pharmacy4 citations Open access
Semantic Scholar
Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors
C. Wysham, P. Lefebvre, D. Pilon, M. Ingham +6 more
2017BMC Endocrine Disorders4 citations Open access
Semantic Scholar
Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis.
J. Tkacz, M. Ingham, B. Brady, R. Meyer +1 more
2015American health & drug benefits4 citations
Semantic Scholar
PMH9 ESTIMATING COST-EFFECTIVENESS OF CONCERTA OROS IN ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (ADHD)—ADAPTING THE CANADIAN COORDINATING OFFICE FOR HEALTH TECHNOLOGY ASSESSMENT'S (CCOHTA) ECONOMIC MODEL OF METHYLPHENIDATE IMMEDIATE RELEASE VERSUS BEHAVIOURAL INTERVENTIONS FROM A PARENT'S PERSPECTIVE
L. Annemans, M. Ingham
20024 citations Open access
Semantic Scholar
Effectiveness of step therapy policies for specialty pharmaceuticals in immune disorders
C. Kozma, M. Ingham, A. Paris, L. Ellis
2013Journal of Medical Economics3 citations Open access
Semantic Scholar
COGNITIVE DEBRIEFING OF THE SF-36V2 WITH MODERATE-TO-SEVERE CROHN’S DISEASE PATIENTS
M. White, A. Yarlas, M. Ingham, C. Han
20162 citations Open access
Semantic Scholar
PMH59 THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY—E-STAR: BASELINE RESULTS FOR GERMANY, SPAIN AND AUSTRALIA
D. Rossillon, S. Caleo, D. Farmer, M. Ingham +1 more
20052 citations Open access
Semantic Scholar
PMH7 THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY—E-STAR: AN ELECTRONIC REGISTRY TO EVALUATE OUTCOMES DATA IN PATIENTS WITH SCHIZOPHRENIA/SCHIZOAFFECTIVE DISORDER
D. Farmer, B. Claerhout, A. Mehnert, M. Ingham
20042 citations Open access
Semantic Scholar
Non-Medical Switching or Discontinuation Patterns among Patients with Non-Valvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States: A Claims-Based Analysis
M. Ingham, H. Romdhani, Aarti Patel, Veronica Ashton +4 more
2024Journal of Market Access & Health Policy1 citations Open access
Semantic Scholar
Real-World Comparative Effectiveness, Treatment Patterns, and Costs in Type 2 Diabetes Mellitus (T2DM) Patients Initiated on Canagliflozin 300 mg (CANA) or a Glucagon-Like Peptide-1 Receptor Agonist (GLP-1)
M. Singhal, Hiangkiat Tan, C. Coleman, W. Herman +3 more
2018Diabetes1 citations
Semantic Scholar
ESICON 2017 Abstracts
M. Mengade, Babul Reddy, Jubin K. Kurian, Kishan Delampady +496 more
2017Indian journal of endocrinology and metabolism1 citations Open access
Semantic Scholar
HbA1c Levels, Persistence, Treatment Progression, and Durability of HbA1c Control in Patients with T2DM Initiated on Canagliflozin or a GLP-1 in a Real-world Setting
C. Wysham, P. Lefebvre, D. Pilon, M. Lafeuille +4 more
20171 citations
Semantic Scholar
Su1014 Evidence of Content Validity and Psychometric Properties of Sf-36 for Measuring Health-Related Quality of Life of Patients With Crohn's Disease
A. Yarlas, M. White, M. Ingham, Cheng-Long Han
20161 citations
Semantic Scholar
Validation Of The Compliance-Questionnaire-Rheumatology, A Behavior-Focused Predictive Adherence Questionnaire, With The Morisky Medication Adherence Scale
R. Pedersini, A. Goren, M. Ingham
20141 citations Open access
Semantic Scholar
Health care costs by level of adherence for infliximab patients with crohn’s disease
S. Michels, L. T. Ten Eyck, J. Vanderpoel, J. Lofland +3 more
20141 citations Open access
Semantic Scholar
Muscle disorders111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study
R. Campbell, D. Hofmann, S. Hatch, P. Gordon +496 more
20121 citations Open access
Semantic Scholar
PMS21 Mapping Health Care Costs to Clinical Disease Activity Where Cost Data is Lacking – A Novel Approach Using Medical Expenditure Panel Survey Data with the Corrona Rheumatoid Arthritis Disease Registry
M. Ingham, V. Ghushchyan, G. Reed, D. Decktor +3 more
20121 citations Open access
Semantic Scholar
PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNS
C. Schmeichel-mueller, E. Buysman, Susan C. Bolge, M. Ingham +1 more
20111 citations Open access
Semantic Scholar
PDB25 THE ECONOMIC IMPACT OF WEIGHT LOSS FOR PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS (T2DM) IN THE US
M. Willis, C. Asseburg, C. Neslusan, J. He +1 more
20101 citations Open access
Semantic Scholar
PMH20 RELATION BETWEEN SYMPTOMS IN SCHIZOPHRENIA AND RISK OF HARM TO SELF AND OTHERS
B. Heeg, W. Cahn, M. Meijboom, M. Ingham +3 more
20051 citations Open access
Semantic Scholar
The impact of neuroleptic treatment on the quality of life of stable schizophrenic patients
B. Arnould, A. Lehman, M. Ingham, S. Bréand +1 more
20011 citations
Semantic Scholar
HTA48 Coverage and Reimbursement of Cell and Gene Therapies: Population Health Versus Individual Patient Perspectives
W. Crown, M. Ingham
2023Value in Health0 citations
Semantic Scholar
DIFFERENCES BETWEEN PATIENT AND PHYSICIAN PERSPECTIVES TOWARD STARTING BIOLOGICS: STRATIFICATION BY MINORITY PATIENT RESPONSE VERSUS WHITE/UNDETERMINED PATIENT RESPONSE
A. Teeple, M. Kariburyo, M. Ingham, H. Tan +1 more
20160 citations Open access
Semantic Scholar
Potential patient-reported Predictors of openness to and preference for Biologic Therapy among patients with Inflammatory Bowel Disease
A. Goren, A. Teeple, M. Ingham
20150 citations Open access
Semantic Scholar
2-Year Follow-Up Of Persistence Of Infusion And Self-Administered Biologics Across Indications
C. Kozma, A. Paris, M. Ingham
20140 citations Open access
Semantic Scholar
Dose Escalation For Infusion Biologics With Flexible Dosing Schedules
C. Kozma, A. Paris, M. Ingham
20140 citations Open access
Semantic Scholar
Relative adherence across sites-of-care for infliximab patients with crohn’s disease
S. Michels, L. T. Ten Eyck, J. Vanderpoel, J. Lofland +3 more
20140 citations Open access
Semantic Scholar
AB0481 Demonstrated, quantifiable benefits in patient reported outcomes supporting a “treat to target” paradigm for infliximab-treated RA patients previously inadequately responsive to prior anti-TNF treatment
M. Ingham, L. Tang, D. Decktor, R. Bolce +1 more
20130 citations
Semantic Scholar
Quantifying the impact of differing measures used to study persistence and adherence with the infusible anti-inflammatory biologic infliximab: Utilization from real-world medical practice
R. Romanelli, Angela Leahy, Trevor Jukes, L. Ellis +2 more
20130 citations Open access
Semantic Scholar
Identifying potentially non-adherent rheumatology patients: Application of the Compliance-Questionnaire-Rheumatology
M. Ingham, S. Bolge, L. Kopenhafer
20130 citations Open access
Semantic Scholar
PMS53 Using Scatter Plots, Analysis of Univariate Relationship Between Confounders and Outcomes among Rheumatoid Arthritis Patients Who Initiated Anti-Tumor Necrosis Factors and Subsequently Switched or Escalated
O. Baser, C. Schmeichel-mueller, M. Ingham
20120 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Lafeuille×7
Invite
M. Lafeuille — researcher profile on SciRah
C. Wysham×6
Invite
C. Wysham — researcher profile on SciRah
D. Pilon×6
Invite
D. Pilon — researcher profile on SciRah
B. Emond×6
Invite
B. Emond — researcher profile on SciRah

Rhiannon L. Kamstra

×6

Invite

Rhiannon L. Kamstra — researcher profile on SciRah

Invite

M. Pfeifer — researcher profile on SciRah

Invite

P. Lefebvre — researcher profile on SciRah

Invite

J. Lofland — researcher profile on SciRah

Invite

S. Bolge — researcher profile on SciRah

Invite

C. Coleman — researcher profile on SciRah

Invite

L. Ellis — researcher profile on SciRah

Invite

S. Caleo — researcher profile on SciRah